Literature DB >> 12233882

Expression of hepatocyte growth factor and its receptor (c-met) in skin fibroblasts from patients with systemic sclerosis.

Yasushi Kawaguchi1, Masayoshi Harigai, Masako Hara, Chikako Fukasawa, Kae Takagi, Michi Tanaka, Eiichi Tanaka, Emi Nishimagi, Naoyuki Kamatani.   

Abstract

OBJECTIVE: To determine the effect of excessive induction of hepatocyte growth factor (HGF)/c-met signaling in fibroblasts derived from patients with systemic sclerosis (SSc).
METHODS: Fibroblasts were obtained from skin of patients with SSc and healthy controls. The 2.4 kb interleukin 1alpha (IL-1alpha) cDNA was subcloned into pcDNA3 expression vector, which was stably transfected into normal fibroblasts by lipofection. HGF production in cultured fibroblasts was measured by ELISA. C-met protein (a receptor for HGF) in cultured fibroblasts was evaluated by immunocytochemistry using polyclonal anti-c-met antibody. Production of procollagen type I was estimated by an ELISA system using antibodies against procollagen type I C-peptide.
RESULTS: Cultured skin fibroblasts expressed mRNA and protein of HGF constitutively in both SSc and control cultures. However, HGF production in SSc fibroblasts was significantly higher than in normal fibroblasts. In both SSc and normal fibroblasts, HGF production was dose dependently increased by the addition of recombinant IL-1alpha. Immunocytochemical staining revealed that c-met was spontaneously expressed in SSc fibroblasts, whereas no expression of c-met was detected in normal fibroblasts. C-met mRNA was expressed in normal fibroblasts transfected with the IL-1alpha gene. Addition of recombinant HGF (100 ng/ml) to cultured SSc fibroblasts significantly decreased procollagen type I production.
CONCLUSION: High concentration of HGF inhibited collagen production in cultured fibroblasts derived from patients with SSc. Overexpression of HGF/c-met appears to be a biological feedback response to the fibrotic process of SSc, suggesting that the antifibrotic effect of HGF might be used as a novel strategy for treatment of SSc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12233882

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  10 in total

Review 1.  Microvascular damage in systemic sclerosis: detection and monitoring with biomarkers.

Authors:  Laura K Hummers
Journal:  Curr Rheumatol Rep       Date:  2006-04       Impact factor: 4.592

2.  Overexpression of c-Met and CD44v6 receptors contributes to autocrine TGF-β1 signaling in interstitial lung disease.

Authors:  Shibnath Ghatak; Galina S Bogatkevich; Ilia Atnelishvili; Tanjina Akter; Carol Feghali-Bostwick; Stanley Hoffman; Victor M Fresco; John C Fuchs; Richard P Visconti; Roger R Markwald; Subhas B Padhye; Richard M Silver; Vincent C Hascall; Suniti Misra
Journal:  J Biol Chem       Date:  2013-12-09       Impact factor: 5.157

3.  M10, a caspase cleavage product of the hepatocyte growth factor receptor, interacts with Smad2 and demonstrates antifibrotic properties in vitro and in vivo.

Authors:  Ilia Atanelishvili; Yuichiro Shirai; Tanjina Akter; Taylor Buckner; Atsushi Noguchi; Richard M Silver; Galina S Bogatkevich
Journal:  Transl Res       Date:  2015-12-19       Impact factor: 7.012

4.  Abnormalities in the regulators of angiogenesis in patients with scleroderma.

Authors:  Laura K Hummers; Amy Hall; Fredrick M Wigley; Michael Simons
Journal:  J Rheumatol       Date:  2009-02-17       Impact factor: 4.666

5.  Matrix metalloproteinase-1 up-regulation by hepatocyte growth factor in human dermal fibroblasts via ERK signaling pathway involves Ets1 and Fli1.

Authors:  Masatoshi Jinnin; Hironobu Ihn; Yoshihiro Mimura; Yoshihide Asano; Kenichi Yamane; Kunihiko Tamaki
Journal:  Nucleic Acids Res       Date:  2005-06-21       Impact factor: 16.971

6.  D1398G Variant of MET Is Associated with Impaired Signaling of Hepatocyte Growth Factor in Alveolar Epithelial Cells and Lung Fibroblasts.

Authors:  Ilia Atanelishvili; Yuichiro Shirai; Tanjina Akter; Atsushi Noguchi; Kurt T Ash; Suniti Misra; Sibnath Ghatak; Richard M Silver; Galina S Bogatkevich
Journal:  PLoS One       Date:  2016-09-01       Impact factor: 3.240

7.  c-Met as a new marker of cellular senescence.

Authors:  Maria Boichuck; Jonathan Zorea; Moshe Elkabets; Marina Wolfson; Vadim E Fraifeld
Journal:  Aging (Albany NY)       Date:  2019-05-13       Impact factor: 5.682

8.  Human Cytomegalovirus and Human Herpesvirus 6 Coinfection of Dermal Fibroblasts Enhances the Pro-Inflammatory Pathway Predisposing to Fibrosis: The Possible Impact on Systemic Sclerosis.

Authors:  Irene Soffritti; Maria D'Accolti; Clara Maccari; Francesca Bini; Eleonora Mazziga; Flora de Conto; Adriana Calderaro; Maria-Cristina Arcangeletti; Elisabetta Caselli
Journal:  Microorganisms       Date:  2022-08-08

9.  Abnormally differentiating keratinocytes in the epidermis of systemic sclerosis patients show enhanced secretion of CCN2 and S100A9.

Authors:  Joanna Nikitorowicz-Buniak; Xu Shiwen; Christopher P Denton; David Abraham; Richard Stratton
Journal:  J Invest Dermatol       Date:  2014-06-16       Impact factor: 8.551

10.  TGF-β Negatively Regulates CXCL1 Chemokine Expression in Mammary Fibroblasts through Enhancement of Smad2/3 and Suppression of HGF/c-Met Signaling Mechanisms.

Authors:  Wei Bin Fang; Benford Mafuvadze; Min Yao; An Zou; Mike Portsche; Nikki Cheng
Journal:  PLoS One       Date:  2015-08-07       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.